May 29th 2024, 4:09pm
Turning the focus to ibrutinib-based therapy, Yuliya Linhares, MD, gives an overview of the RESONATE study.
May 22nd 2024, 8:22pm
Expert perspectives on the SEQUOIA study, which is investigating zanubrutinib in patients with chronic lymphocytic leukemia.
May 22nd 2024, 8:18pm
Yuliya Linhares, MD, discusses the CLL14 study, which is looking at venetoclax plus obinutuzumab in patients with previously untreated chronic lymphocytic leukemia.
May 15th 2024, 1:49pm
Focusing on acalabrutinib-based treatment, Yuliya Linhares, MD, discusses results from the ELEVATE TN clinical trial.
May 15th 2024, 1:42pm
A general overview of efficacy and safety data for current treatment options for patients with chronic lymphocytic leukemia.
May 13th 2024, 7:20pm
“I think there is a very near future where we have available breast cancer vaccines for all of us, our children and for everybody,” said Kristen Dahlgren.
May 9th 2024, 7:30pm
An oncology nurse discusses what patients should know before BiTE therapy, and what they can do if they do not have a social support system.
May 8th 2024, 5:06pm
Josie Montegaard, MSN, AGPCNP-BC, offers expert perspectives on treatment considerations in CLL, focusing on BTK inhibitors and venetoclax-based therapy.
May 8th 2024, 4:38pm
Dr Linhares provides clinical insights on factors that guide treatment decisions for patients with chronic lymphocytic leukemia, such as comorbidities and disease biology.
May 7th 2024, 9:00pm
Jessica McDade, B.S.N., RN, OCN, explains how she helps make her patients’ experience “a little less daunting” during their hospital stay.
Finally Learning to Put Myself First
Experts Discuss Next Steps in Perioperative Bladder Cancer Treatment
Signatera Guides Bladder Cancer Treatment After Surgery
What If? Embracing Hope During a Cancer Journey